why choose us

First received: March 21, 2023

Clinical Trial: A Study to Understand the Safety and Effects of New Formulations of a Clostridioides Difficile Vaccine Shot That Will be Given to Healthy Adults

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Clostridoides Difficile Associated Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Randomized and Phase 2 Study to Evaluate the Safety, Tolerability, Immunogenicity, and Immunopersistence of a Clostridioides Difficile Vaccine Administered in a 2-Dose Regimen With Novel Adj

Brief Summary: An antibody is a substance your body makes to fight off infection.This study will explore the safety and antibody response of a vaccine to prevent severe diarrhea caused by a germ called Clostridoides difficile (C.diff).Three new formulations of the C. diff vaccine will be used in this study, in addition to a C. diff vaccine formulation that has been studied in previous clinical trials.The purpose of this study is to understand if giving the new C. diff vaccine formulations helps people make as many antibodies as…

Read more